MDNC · Medinotec Inc.
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|---|
| $10.25M | $9.73M | $9.11M | $5.02M | $999.58K | |
| $4.72M | $4.6M | $4.3M | -$2.58M | -$417.76K | |
| $5.52M | $5.13M | $4.82M | $2.44M | $581.82K | |
| — | 52.71% | 52.87% | 48.65% | 58.21% | |
| $108.81K | $149.86K | $91.13K | -$22.35K | -$64.87K | |
| $1.97M | $1.49M | $113.19K | -$84.56K | -$53.82K | |
| $2.35M | $2.32M | $1.35M | -$1.67M | -$648.17K | |
| $94.65K | $80.87K | $73.85K | $88.23K | $53.55K | |
| -$4.52M | -$4.03M | -$1.63M | -$1.84M | -$820.41K | |
| $997.93K | $1.09M | $3.19M | $600.58K | -$238.59K | |
| — | 11.25% | 35.02% | 11.96% | -23.87% | |
| $1.09M | $1.18M | $3.27M | $688.8K | -$185.03K | |
| $62.54K | $87.6K | $176.42K | -$277.23K | -$226.81K | |
| $16.99K | -$25.33K | -$167.36K | -$854.35K | -$152.89K | |
| $1.01M | $1.07M | $3.02M | -$253.77K | -$391.48K | |
| — | -$274.69K | -$864.67K | -$150.92K | $38.74K | |
| $902.73K | $794.5K | $2.16M | -$404.69K | -$352.74K | |
| — | 8.17% | 23.7% | -8.06% | -35.29% | |
| $1.37M | $1.33M | $2.1M | -$388.88K | -$272.09K | |
| USD/shares | $0.08 | $0.07 | $0.18 | -$0.03 | -$0.03 |
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 72 similar-size Medical Devices companies (of 144 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Outside USA Distribution Agreement Sales | $8,141,634 | $7,572,165 | $3,490,133 | — |
| Outside USA Internally Designed Manufactured Sales | $975,969 | $863,337 | $976,291 | — |
| Inside USA Internally Designed Manufactured Sales | $611,860 | $678,105 | $553,967 | — |
| Inside the United States | — | — | — | $21,467 |
| Outside the United States | — | — | — | $978,112 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Outside the United States | $1,655,122 | $3,442,700 | $602,156 | $10,822 |
| Inside the United States | -$560,610 | -$251,201 | -$1,578 | -$249,409 |
Operating Margin by Segment (%)
| Component | FY2023 |
|---|---|
| Inside the United States | -1161.8% |
| Outside the United States | 1.1% |